The IPFnet Strategy: Creating a Comprehensive Approach in the Treatment of Idiopathic Pulmonary Fibrosis
- 15 March 2010
- journal article
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 181 (6) , 527-528
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Short telomeres are a risk factor for idiopathic pulmonary fibrosisProceedings of the National Academy of Sciences, 2008
- Assessment of current practice in the diagnosis and therapy of idiopathic pulmonary fibrosisRespiratory Medicine, 2008
- Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms?European Respiratory Journal, 2007
- State of the Art. Does Current Knowledge Explain the Pathogenesis of Idiopathic Pulmonary Fibrosis?: A PerspectiveProceedings of the American Thoracic Society, 2007
- Adult-onset pulmonary fibrosis caused by mutations in telomeraseProceedings of the National Academy of Sciences, 2007
- Telomerase Mutations in Families with Idiopathic Pulmonary FibrosisNew England Journal of Medicine, 2007
- Incidence and Prevalence of Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Genetics of fibrosing lung diseasesEuropean Respiratory Journal, 2005
- Future Research Directions in Idiopathic Pulmonary Fibrosis: Summary of a National Heart, Lung, and Blood Institute Working GroupAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus StatementAmerican Journal of Respiratory and Critical Care Medicine, 2000